Sell Sun Pharma, target Rs 565: Kunal Bothra
Sell Sun Pharmaceutical Industries Ltd. at a price target of Rs 565.0 and a stoploss at Rs 600 from entry point.
Sun pharma invests 120 crore in Assam to set up production line
According to statement from Assam government the company has already invested...
India, Azerbaijan to take steps to boost bilateral trade
The issues were discussed during the fifth meeting of the India-Azerbaijan Inter-Gov...
How Indian family businesses are taking on MNCs in deodorant industry
After a dream run, the deodorant industry is facing hyper-competition and shrinking margins.
Eyeing trade ties, India pitches for defence industrial park
“There are many opportunities in India that Russian businesses can take account of, like the Sagarmala project, metro projects, and others," the PM said.
Drug makers may have to pay 5 times more for pharma imports
The ministry is once again mulling a hike in fees for several regulatory submissions for foreign drug makers, said two senior health ministry officials.
PE firm Advent acquires Manjushree Technopack
As part of the transaction, Advent purchased all the shares owned by existing investor Kedaara Capital and a portion of the promoters Kedia family’s stake in Manjushree Technopack.
Share market update: Nifty Pharma in the green; Sun Pharma, Cipla climb 1%
Benchmark NSE Nifty50 index was down 133 points at 10,467, while the BSE Sensex was 328 points down at 34,841.
Stock market update: Pharma stocks crack; Biocon, Lupin top losers in Nifty Pharma index
The Nifty Pharma index was trading 2.16 per cent down at 9,736 around 1 pm with all components in the red.
Buy Sun Pharmaceutical Industries, target Rs 618: Dr CK Narayan
Buy Sun Pharmaceutical Industries Ltd. at a price target of Rs 618.0 and a stoploss at Rs 595 from entry point.
163 ultra rich Delhiites have cumulative wealth of Rs 6,78,400 crore: Barclays Hurun
The Barclays Hurun India Rich List, which is a compilation of the richest individuals in India having a net worth of Rs 1,000 crore or more, noted that in terms of cities, Mumbai emerged as the hub of the rich and famous.
TCI Express expecting 18-19% volume growth this year: Chander Agarwal
“We are not seeing much uptick in cost because we have a very dynamic diesel fuel surcharge system.”
Mankind Pharma eyes $1 billion topline by 2021
The company is also looking at increasing its exports substantially to USD 100-150 USD million in the next three years from the present USD 10 million.
Share market update: Pharma stocks in pain; Piramal Enterprises cracks 6%
The Nifty Pharma index was trading 1.53 per cent down at 10,132 around 02:25 pm.